🔎 Trials Near Me

홈 › 림프종 › 일리노이

일리노이의 림프종 임상 시험

림프종 관련 연구 23개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07015242

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
피험자 모집 중1/2상
12 Months – 21 Years · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT04870944

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • University of Illinois Cancer Center, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06624085

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, Chicago
피험자 모집 중3상
18세 ~ 18세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07509151

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • City of Hope - Chicago, Zion
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04588922

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

  • University of Chicago, Chicago
  • Northwestern University, Evanston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • University of Chicago Medical Center, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • The David and Etta Jonas Center for Cellular Therapy, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Northwestern, Chicago
  • University of Chicago, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

  • Northwestern University Feinberg School of Medicine, Chicago
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06960993

DALY II USA/ MB-CART2019.1 for DLBCL

  • Robert H Lurie Cancer Center, Chicago
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  • Call for Information (Investigational Site 0024), Chicago
피험자 모집 중1/2상
6 Months – 17 Years · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT02332668

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • Northwestern University, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Lurie Children's Hospital-Chicago, Chicago
  • Advocate Children's Hospital-Oak Lawn, Oak Lawn
  • Saint Jude Midwest Affiliate, Peoria
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Northwestern Memorial Hospital, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • University of Illinois at Chicago Cancer Center, Chicago
피험자 모집 중1/2상
12세 ~ 95세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04329728

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

  • City of Hope Chicago, Zion
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06915246

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • The University of Chicago Medical Center, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 20. 업데이트됨 · NCT04830137

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 4. 업데이트됨 · NCT07294677

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • University of Chicago Comprehensive Cancer Center, Chicago
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 2. 20. 업데이트됨 · NCT05745285

Avo In R/R And Previously Untreated MCL

  • University of Chicago Medical Center, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT04855695

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • OSF Saint Anthony's Health Center, Alton
피험자 모집 중3상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 1. 13. 업데이트됨 · NCT05006482

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 22. 업데이트됨 · NCT04234048

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.